MR编号 | PT/H/2388/001 |
---|
药品名称 | Salmeterol/Fluticasone Genetic 25 microgram/50 microgram pressurized inhalation, suspension |
---|
活性成分 | - Fluticasone propionate 50.0 µg
- Salmeterol xinafoate 25.0 µg
|
---|
剂型 | Pressurised inhalation, suspension |
---|
上市许可持有人 | GENETIC SPA
VIA G DELLA MONICA 26
CASTEL SAN GIORGIO SA
I-84083
ITALY |
---|
参考成员国 - 产品名称 | Portugal (PT) |
---|
互认成员国 - 产品名称 | - United Kingdom (Northern Ireland) (XI)
Salmeterol/Fluticasone Genetic 25 microgram/50 microgram pressurized inhalation, suspension - Germany (DE)
Salmeterol/Fluticasone Genetic 25 microgram/50 microgram per metered dose pressurized inhalation, suspension - France (FR)
- Italy (IT)
- Greece (GR)
- Bulgaria (BG)
Salmeterol/fluticasone Genetic - Czechia (CZ)
Salmeterol/Fluticasone Genetic 25 microgram / 50 microgram per metered dose pressurized inhalation, suspension. - Romania (RO)
- Slovakia (SK)
- Slovenia (SI)
|
---|
许可日期 | 2019/02/20 |
---|
最近更新日期 | 2024/12/19 |
---|
药物ATC编码 | - R03AK06 salmeterol and fluticasone
|
---|
申请类型 | - TypeLevel1:[not specified]
- TypeLevel2:[not specified]
- TypeLevel3:[not specified]
- TypeLevel4:[not specified]
- TypeLevel5:[not specified]
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|